Liothyronine Sodium
These highlights do not include all the information needed to use LIOTHYRONINE SODIUM TABLETS, USP safely and effectively. See full prescribing information for LIOTHYRONINE SODIUM TABLETS, USP. LIOTHYRONINE SODIUM TABLETS, USP, for oral use Initial U.S. Approval: 1956
38ef3766-bb9a-402e-9e4a-ad8bb5b26e4c
HUMAN PRESCRIPTION DRUG LABEL
Jan 10, 2023
SIGMAPHARM LABORATORIES, LLC
DUNS: 556234636
Products 3
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Liothyronine Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Liothyronine Sodium
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
Liothyronine Sodium
Product Details
FDA regulatory identification and product classification information